Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 37.5438.9425.3832.8950.80

What is the latest EV/EBIT ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EV/EBIT ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 37.54 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202537.54
Mar202438.94
Mar202325.38
Mar202232.89
Mar202150.80

How is EV/EBIT of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 37.54
-3.60
Mar2024 38.94
53.43
Mar2023 25.38
-22.83
Mar2022 32.89
-35.26
Mar2021 50.8 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EV/EBIT ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹39,787.0 Cr -1.1% -9.3% 14.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,497.0 Cr -3.5% -6.4% -2.6% Stock Analytics
DIVIS LABORATORIES ₹165,492.0 Cr -5.8% -1.6% 10.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,013.0 Cr 1.4% 7% 23.7% Stock Analytics
CIPLA ₹112,922.0 Cr -4.7% -6.8% -0.3% Stock Analytics
DR REDDYS LABORATORIES ₹98,115.0 Cr -2.8% -8.1% -11.1% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-1.1%

-9.3%

14.5%

SENSEX

-0.7%

-1.9%

8%


You may also like the below Video Courses